Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-01-30
1997-03-11
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, A61K 3824
Patent
active
056101368
ABSTRACT:
The present invention is directed to methods of treating benign prostatic hypertrophy comprising the step of administering to a subject suffering from benign prostatic hypertrophy a chorionic gonadotropin or a pharmaceutically active fragment or derivative thereof in an amount effective to alleviate one or more symptoms of benign prostatic hypertrophy.
REFERENCES:
patent: 4002738 (1977-01-01), Johnson et al.
patent: 4116776 (1978-09-01), Dalbow et al.
patent: 4144031 (1979-03-01), Acevedo et al.
patent: 4201770 (1980-05-01), Stevens
patent: 4228127 (1980-10-01), Acevedo et al.
patent: 4302386 (1981-11-01), Stevens
patent: 4321260 (1982-03-01), Auclair
patent: 4384995 (1983-05-01), Stevens
patent: 4526716 (1985-07-01), Stevens
patent: 4691006 (1987-09-01), Stevens
patent: 4692332 (1987-09-01), McMichael
Acevedo et al., "Expression of Membrane-Associated Human Chorionic Gonadotrophin, Its Subunits, and Fragments by Cultured Human Cancer Cells," Cancer, 69:1829-1842 (1992).
Acevedo et al., "Human Chorionic Gonadotropin-Beta Subunit Gene Expression in Cultured Human Fetal and Cancer Cells of Different Types and Origins," Cancer, 76:1467-1475 (1995).
Fauve et al., "Antiinflammatory Effects of Murine Malignant Cells," Proc. Nat'l Acad. Sci. USA, 71(10):4052-4056 (Oct., 1974).
Hanna et al., "Relationship Between Metastatic Potential and Resistance to Natural Killer Cell-Mediated Cytotoxicity in Three Murine Tumor Systems," JNCL, 66:1183-1190 (Jun., 1981).
Imecik et al., "Diagnostic Value of Sialic Acid in Malignant Pleural Effusions," Chest, 102:1819-1822 (1992).
Regelson, W., Have We Found the "Definitive Cancer Biomarker"?, Cancer, 76(8):1299-1474 (Oct. 15, 1995).
Triozzi et al., "Clinical and Immunologic Effects of a Synthetic .beta.-Human Chorionic Gonadotropin Vaccine," Inter. J. Oncol., 5:1447-1453 (1994).
van Beek et al., "Increased Sialic Acid Density in Surface Glycoprotein of Transformed and Malignant Cell-a General Phenomeon?," Can. Res., 33:2913-2922 (Nov., 1973).
Milkhaus Laboratory, Inc.
Schain Howard E.
LandOfFree
Method for treatment of benign prostatic hypertrophy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treatment of benign prostatic hypertrophy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treatment of benign prostatic hypertrophy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-443558